Alfons J. M. den Eertwegh

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors.

N. Agarwal, C. Drake, H. Scher, 2020, European urology.

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

I. Lowy, T. D. de Gruijl, K. Jooss, 2013, Cancer Immunology, Immunotherapy.

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib

D. Kuik, J. Haanen, H. Verheul, 2009, Angiogenesis.

Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

C. Blank, G. Hospers, G. Vreugdenhil, 2022, Annals of Surgical Oncology.